Tags

Type your tag names separated by a space and hit enter

Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection.
Vasc Endovascular Surg 2020; 54(1):12-16VE

Abstract

PURPOSE

To investigate the clinical outcomes of endovascular bare stenting in patients with symptomatic isolated superior mesenteric artery (SMA) dissection (ISMAD).

METHODS

This study was a retrospective analysis which included a total of 9 patients with symptomatic ISMAD (7 males and 2 females, age range: 48-67 years) who were treated with endovascular bare stenting. Data regarding basic patient clinical characteristics, e-technical success of the operation, and long-term patient outcomes were assessed.

RESULTS

Endovascular bare stenting was found to be technically successful in all patients. A total of 9 stents were inserted in these 9 patients. Five patients presented with stable false lumen and 4 patients presented with shrinking of false lumen after stenting. Both the trunk and branches of the SMA remained patent in all patients after stent insertion. There was no incidence of procedure-related complications, with all patients experiencing progressive symptom relief and subsequent symptom abatement within 1 week of the operation. Over a median 24 month follow-up period (range: 12-36 months), abdominal computed tomographic angiography revealed that all patients had obliterated dissections. In addition, there were no instances of stent obstruction, intestinal necrosis, or antiplatelet related bleeding during the follow-up period.

CONCLUSIONS

Endovascular bare stenting was found to be a safe and effective treatment for patients with ISMAD.

Authors+Show Affiliations

Department of Radiology, Xuzhou Central Hospital, Xuzhou, China.Department of Radiology, Xuzhou Central Hospital, Xuzhou, China.Department of Radiology, Xuzhou Central Hospital, Xuzhou, China.Department of General Surgery, Xuzhou Central Hospital, Xuzhou, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31522622

Citation

Fu, Yu-Fei, et al. "Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection." Vascular and Endovascular Surgery, vol. 54, no. 1, 2020, pp. 12-16.
Fu YF, Cao C, Shi YB, et al. Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection. Vasc Endovascular Surg. 2020;54(1):12-16.
Fu, Y. F., Cao, C., Shi, Y. B., & Song, T. (2020). Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection. Vascular and Endovascular Surgery, 54(1), pp. 12-16. doi:10.1177/1538574419874933.
Fu YF, et al. Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection. Vasc Endovascular Surg. 2020;54(1):12-16. PubMed PMID: 31522622.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Endovascular Bare Stenting for Isolated Superior Mesenteric Artery Dissection. AU - Fu,Yu-Fei, AU - Cao,Chi, AU - Shi,Yi-Bing, AU - Song,Tao, Y1 - 2019/09/16/ PY - 2019/9/17/pubmed PY - 2019/12/21/medline PY - 2019/9/17/entrez KW - bare stent KW - dissection KW - superior mesenteric artery SP - 12 EP - 16 JF - Vascular and endovascular surgery JO - Vasc Endovascular Surg VL - 54 IS - 1 N2 - PURPOSE: To investigate the clinical outcomes of endovascular bare stenting in patients with symptomatic isolated superior mesenteric artery (SMA) dissection (ISMAD). METHODS: This study was a retrospective analysis which included a total of 9 patients with symptomatic ISMAD (7 males and 2 females, age range: 48-67 years) who were treated with endovascular bare stenting. Data regarding basic patient clinical characteristics, e-technical success of the operation, and long-term patient outcomes were assessed. RESULTS: Endovascular bare stenting was found to be technically successful in all patients. A total of 9 stents were inserted in these 9 patients. Five patients presented with stable false lumen and 4 patients presented with shrinking of false lumen after stenting. Both the trunk and branches of the SMA remained patent in all patients after stent insertion. There was no incidence of procedure-related complications, with all patients experiencing progressive symptom relief and subsequent symptom abatement within 1 week of the operation. Over a median 24 month follow-up period (range: 12-36 months), abdominal computed tomographic angiography revealed that all patients had obliterated dissections. In addition, there were no instances of stent obstruction, intestinal necrosis, or antiplatelet related bleeding during the follow-up period. CONCLUSIONS: Endovascular bare stenting was found to be a safe and effective treatment for patients with ISMAD. SN - 1938-9116 UR - https://www.unboundmedicine.com/medline/citation/31522622/Endovascular_Bare_Stenting_for_Isolated_Superior_Mesenteric_Artery_Dissection_ L2 - http://journals.sagepub.com/doi/full/10.1177/1538574419874933?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -